Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...

Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron that just showed positive results from a ...

Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way than popular GLP-1 drugs, like Ozempic. While injectable GLP-1s work by ...

Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral GLP-1 pill being studied for the treatment of type 2 diabetes and obesity, ...

A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy and Zepbound are racing to launch once-daily oral versions that may help people ...

A groundbreaking experimental pill shows promise for weight loss, potentially allowing individuals to shed fat without ...

Next-generation pills and monthly injectables promise more choice, fewer side effects and broader health benefits.

Dec 12 () - The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector ...

A new oral GLP-1 receptor agonist, orforglipron, is revolutionizing weight management by offering a needle-free alternative ...

"Ozempic 2.0" has been floating around online, as a trending nickname for the next generation of weight loss drugs that are in the works.

The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector currently ...